Local News: Marion, IL 

 | 

Sign Up

 | 

Sign In

Advertisment

Enzon Pharmaceuticals

Enzon Pharmaceuticals News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Enzon Pharmaceuticals News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Enzon Pharmaceuticals News

News on Enzon Pharmaceuticals continually updated from thousands of sources around the net.

7 hrs ago | Freshnews

Enzon Sets Date of Special Meeting of Stockholders to Approve Sale of ...

Enzon Pharmaceuticals, Inc. announced today that it has set Wednesday, January 27, 2010 as the date of the special meeting of stockholders to vote on the proposed sale of its specialty pharmaceutical business to the sigma-tau Group.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, New York Metro

Tue Dec 22, 2009

SanLuisObispo.com

Enzon shareholders to vote on sale on Jan. 27

Enzon Pharmaceuticals Inc. said Tuesday it will hold a shareholder meeting on Jan.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu Dec 10, 2009

Seeking Alpha

Baupost Trims Syneron Stake, Buys More Enzon

In an amended 13G just filed with the SEC, Seth Klarman's hedge fund Baupost Group has disclosed a 5.45% ownership stake in Syneron Medical .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Tue Nov 17, 2009

American Chronicle

Updates for Enzon

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration, Opinion

Pharmaceutical Technology

Week of Nov. 9, 2009: Merck and Schering-Plough Begin Combined Operations; UCB Appoints VP; More...

Under the terms of the agreement, 3M provides its TLR agonists to VaxInnate for an undisclosed licensing fee, in addition to milestone and royalty payments.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Science / Technology, Sweden, World News, Marketing

Sun Nov 15, 2009

GuruFocus.com

Seth Klarman Recent Stock Purchases: Enzon Inc. and ViaSat Inc.

Investment Guru Seth Klarman has been busy buying distressed debt nowadays and he might just ignored stocks.

Comment?

Related Topix: ViaSat, Biotech, Cable & Satellite, Telecom, Medicine, Healthcare Industry, Sales, Schering Plough

Fri Nov 13, 2009

Zacks Analyst Blog

Enzon Beats, Announces Sell-off

Enzon achieved break-even earnings during the third quarter of 2009, better than the Zacks Consensus Estimate of loss of 7 cents but below the year-ago earnings of 1 cent.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, 9, Leukemia, Health

Wed Nov 11, 2009

Seeking Alpha

Baupost Initiates Enzon Position, Ups ViaSat Stake

Seth Klarman's well known hedge fund Baupost Group recently filed two separate 13G's with the SEC in which it updated positions.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, ViaSat, Cable & Satellite, Telecom, Samhain, Life, Holidays

Tue Nov 10, 2009

Star Tribune

W.Va.'s Sen. Rockefeller stands behind coal

U.S. Sen. Jay Rockefeller says current federal energy legislation doesn't do enough to protect West Virginia's coal industry.

Comment?

Related Topix: US Politics, John Rockefeller, US News, US Senate, Democrat, Biotech, Medicine, Healthcare Industry

Mon Nov 09, 2009

Pharmaceutical Processing

Enzon to Sell Its Specialty Pharmaceutical Business to sigma-tau for Approximately $327 million

Enzon Pharmaceuticals, Inc. today announced that it has entered into a definitive agreement to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million plus an additional amount of up to $27 million based on success milestones.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Indianapolis, IN, Indianapolis Metro

Fri Nov 06, 2009

American Chronicle

News and FDA Updates for EpiCept

A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com On 11/03/09, EpiCept Corporation announced a Nasdaq Hearings Panel has granted the Companys request for continued listing on The Nasdaq Stock Market.

Comment?

Related Topix: Healthcare Law, Law, Food and Drug Administration, Biotech, EpiCept, Medicine, Healthcare Industry, GenVec, 9, Opinion

Tue Nov 03, 2009

GuruFocus.com

Enzon Inc. Reports Operating Results

Enzon Inc. filed Quarterly Report for the period ended 2009-09-30. Enzon Pharmaceuticals Inc.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Sales, Schering Plough, Marketing

Thu Oct 29, 2009

American Chronicle

Updates for Arrayit

A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com On 10/28/09, Arrayit Corporation announced the sale of a system to the Center of Excellence for Nucleic Acid-Based Technologies in Poznan, Poland.

Comment?

Related Topix: Food and Drug Administration, World News, Poland, Biotech, Medicine, Healthcare Industry, Science / Technology, BioSphere Medical, Medical Equipment, Opinion

Sat Oct 10, 2009

The US Market Blog

15 Breakout Stocks on Huge Volume

Here is a list of 15 stocks which traded higher Wednesday on unusually higher volume.

Comment?

Related Topix: Financial Markets, Sykes Enterprises, Computers, Advertising, Retail, Apparel, Talbots, Biotech, Medicine, Healthcare Industry

Thu Oct 08, 2009

MediLexicon

UCB's Cimzia(R), The Only PEGylated Anti-TNF, Approved In Europe

Main Category: Arthritis / Rheumatology Also Included In: Regulatory Affairs / Drug Approvals Article Date: 08 Oct 2009 Enzon Pharmaceuticals, Inc.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Rheumatoid Arthritis, Health

Wed Oct 07, 2009

MediLexicon

PEGINTRON(R) Receives A Recommendation For Approval From FDA Advisory ...

Main Category: Melanoma / Skin Cancer Also Included In: Regulatory Affairs / Drug Approvals Article Date: 06 Oct 2009 Enzon Pharmaceuticals, Inc.

Comment?

Related Topix: Skin Cancer, Medicine, Health, Biotech, Healthcare Industry, Hepatitis

Tue Oct 06, 2009

Business Wire

Public relations, press release distribution, investor relations, SEC filing

ENGLEWOOD, Colo.-- --The Western Union Company , lider en la industria de las transferencias de dinero a escala mundial, ha comunicado que la Presidenta y Consejera delega... 10/05/2009 - 02:45 PM ST.

Comment?

Related Topix: Business Wire, Startups, Cardiovascular Systems, Healthcare Industry, Biotech, Medicine, Healthcare Law, Law, Sugar Land, TX, Construction, Deltic Timber

Wed Sep 23, 2009

Zacks Analyst Blog

BioMarin Begins Mid-Stage Trial

Analyst Report ) said it started a mid-stage study of PEG-PAL for the treatment of phenylketonuria .

Comment?

Related Topix: Healthcare Law, Law, Biotech, Merck , Medicine, Healthcare Industry, Food and Drug Administration

Thu Aug 27, 2009

BioWorld

Santaris, Shire Ink $380M+ Deal for Rare Generic Disorder Drugs

Danish firm Santaris Pharma AS racked up another multimillion dollar deal to develop drugs based on its locked nucleic acid platform targeting microRNAs and messenger RNAs, this time with London-based Shire plc for drugs to treat rare genetic disorders.

Comment?

Related Topix: Biotech, Shire plc, Medicine, Healthcare Industry, Chemistry, Science

Wed Aug 26, 2009

BioWorld

Santaris, Shire Ink $380M+ Deal for Rare Generic Disorder Drugs

Danish firm Santaris Pharma AS racked up another multimillion dollar deal to develop drugs based on its locked nucleic acid platform targeting microRNAs and messenger RNAs, this time with London-based Shire plc for drugs to treat rare genetic disorders.

Comment?

Related Topix: Biotech, Shire plc, Medicine, Healthcare Industry, Chemistry, Science

Marion Jobs

Also on Topix